Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Pontus Dunér

Assistant researcher

Default user image.

β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice

Author

  • Vignesh Murugesan
  • Eva Degerman
  • Anki Knutsson
  • Pontus Dunér
  • Ann-Kristin Holmén-Pålbrink
  • Anna Hultgårdh
  • Uwe Rauch

Summary, in English

Background: Smooth muscle cells are important for atherosclerotic
plaque stability. Their proper ability to communicate
with the extracellular matrix is crucial for maintaining
the correct tissue integrity. In this study, we have investigated
the role of β-sarcoglycan within the matrix-binding dystrophin-glycoprotein
complex in the development of atherosclerosis.
Results: Atherosclerotic plaque development
was significantly reduced in ApoE-deficient mice lacking
β-sarcoglycan, and their plaques contained an increase in
differentiated smooth muscle cells. ApoE-deficient mice
lacking β-sarcoglycan showed a reduction in ovarian adipose
tissue and adipocyte size, while the total weight of the
animals was not significantly different. Western blot analysis
of adipose tissues showed a decreased activation of protein
kinase B, while that of AMP-activated kinase was increased
in mice lacking β-sarcoglycan. Analysis of plasma in β-sarcoglycan-deficient
mice revealed reduced levels of leptin,
adiponectin, insulin, cholesterol, and triglycerides but in-
creased levels of IL-6, IL-17, and TNF-α. Conclusions: Our results
indicate that the dystrophin-glycoprotein complex and
β-sarcoglycan can affect the atherosclerotic process. Furthermore,
the results show the effects of β-sarcoglycan deficiency
on adipose tissue and lipid metabolism, which may
also have contributed to the atherosclerotic plaque reduction.

Department/s

  • Vessel Wall Biology
  • Insulin Signal Transduction
  • Cardiovascular Research - Immunity and Atherosclerosis
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year

2017-07-29

Language

English

Pages

235-245

Publication/Series

Journal of Vascular Research

Volume

54

Document type

Journal article

Publisher

Karger

Topic

  • Cardiac and Cardiovascular Systems

Status

Published

Research group

  • Vessel Wall Biology
  • Insulin Signal Transduction
  • Cardiovascular Research - Immunity and Atherosclerosis

ISBN/ISSN/Other

  • ISSN: 1423-0135